Across TCGA pan-cancer cohorts, LINC01153 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01153’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC01153 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01153 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

THCA and COAD are the cancer types where LINC01153 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01153 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.008	.006	3	view →
COAD	All	All	−0.003	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01153 RNA expression & survival · all LINC01153 data types